Conferences - Results from #240

EAU 2023: In Young Patients, Is Prostate-Sparing Radical Cystectomy a Safe Option for Muscle Invasive Bladder Cancer? What About Reproductive Organ-Sparing in Women? Debate March 13, 2023

EAU 2023: Clinical Staging for Bladder Cancer: Have Imaging Techniques Reached a Point Where We Can Avoid TURBT – at Initial Diagnosis? After Neoadjuvant Therapy? March 13, 2023

EAU 2023: Case-Based Debate: What Is the Optimal Treatment for Patients with High-Risk Muscle-Invasive Bladder Cancer Scheduled for Radical Cystectomy? Case Presentation – Use of Both Neoadjuvant and Adjuvant Systemic Therapy? One Is Enough March 13, 2023

EAU 2023: European Urology Oncology Lecture: The Future of Systemic Treatment in Patients with Locally Advanced and Metastatic Renal Cell Carcinoma March 13, 2023

EAU 2023: State-of-the-Art Lecture: PARP Inhibitors: For Which Mutations and When? March 13, 2023

EAU 2023: State-of-the-Art Lecture: Optimal Treatment Sequencing in the Area of Triplet Therapies for Hormone-Sensitive Disease March 13, 2023

EAU 2023: Debate: Is There Any Added Value of Docetaxel in Combination with ADT and ARPI for the Treatment of mHSPC? March 13, 2023

EAU 2023: State-of-the-Art Lecture: What Are the Best Predictive Factors for Successful Treatment with Lu PSMA? March 13, 2023

EAU 2023: State-of-the-Art Lecture: When and How to Sequence (Molecular Testing)? March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Surgical Approach +/- Radiotherapy +/- Systemic Treatment March 13, 2023

EAU 2023: Debate: Low-Volume Disease at Conventional Imaging, 5 Bone Metastases at PSMA PET/CT March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Radiotherapeutic Approach +/- Systemic Treatment March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Subtypes of Prostate Cancer and How They Change our Management March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Systemic Therapy: What and for how long? March 13, 2023

EAU 2023: State-of-the-Art Lecture: Patient-Related Factors That Guide Treatment Decisions March 13, 2023

Delaying Treatment for Localised Prostate Cancer Does Not Increase Mortality Risk, Trial Shows March 12, 2023

Difference Between “Growers” and “Showers” Revealed March 12, 2023

EAU 2023: State-of-the-Art Lecture When and How to Stage? March 12, 2023

EAU 2023: Debate: High-Risk BRCA Mutated Case with N0 M0 at Conventional Imaging and Multiple cN1 at PSMA: What to Do? March 12, 2023

EAU 2023: LuTectomy: A Prospective Study of Dosimetry, Safety and Potential Benefit of Upfront 177Lu-PSMA-617 Radioligand Therapy Prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer March 12, 2023

Page 13 of 518